MDMA study for borderline personality disorder
Treatments studied
Part of Mental health clinical trials.
This trial tests if a single dose of MDMA, given under supervision, can help people with borderline personality disorder (BPD). You will stay overnight after the session and be followed up for two weeks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- You weigh between 110 and 210 pounds.
- You have been diagnosed with borderline personality disorder and have fears of abandonment and stormy relationships.
- You are not currently taking antidepressants, mood stabilizers, antipsychotics, or stimulants.
- You have not used MDMA in the past 6 months and have used ecstasy no more than 10 times in your life.
- You do not have a history of bipolar disorder, schizophrenia, or autism.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether combining mindfulness training with brain scan feedback (neurofeedback) can improve the benefits of regular talk therapy for adults with borderline personality disorder. It takes place at Yale University.
This Phase 2 study tests a new medicine for people with borderline personality disorder (BPD) to see if it can improve symptoms. You may qualify if you have a confirmed BPD diagnosis and meet safety and medication rules.
This study tests whether adding psilocybin (a psychedelic drug) to your regular DBT therapy can help reduce symptoms of borderline personality disorder. Psilocybin is given during therapy sessions and may help you process emotions and improve your relationships.
This study tests whether Eye Movement Desensitization and Reprocessing (EMDR) therapy can help people with Borderline Personality Disorder (BPD). EMDR is a type of talk therapy often used for trauma, and this trial wants to see if it can improve BPD symptoms.
This trial tests whether the medication methylphenidate (brand name Concerta) can help reduce symptoms like impulsivity and mood swings in people with borderline personality disorder. Methylphenidate is typically used for ADHD but may affect brain chemicals related to impulse control.
This study tests talk therapy for couples where one person has borderline personality disorder (BPD). It aims to see if the therapy helps improve symptoms and relationship quality.
Hear when a new Borderline Personality Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.